Objective: To update the 1994 practice parameter for the diagnosis of dementia in the elderly.
Background: The AAN previously published a practice parameter on dementia in 1994. …

Alzheimer disease (AD) is biologically defined by the presence of β-amyloid-containing
plaques and tau-containing neurofibrillary tangles. AD is a genetic and sporadic …

This article provides a classification of primary progressive aphasia (PPA) and its 3 main
variants to improve the uniformity of case reporting and the reliability of research results. …

Despite general agreement about the boundaries of Alzheimer disease (AD), establishing a
maximum limit for Alzheimer-type pathology in cognitively intact individuals might aid in …

The National Institute on Aging and the Alzheimer’s Association charged a workgroup with
the task of revising the 1984 criteria for Alzheimer’s disease (AD) dementia. The workgroup …

Objective: To perform serial neuropsychological assessments to detect vascular risk factors
for cognitive decline in the Atherosclerosis Risk in Communities cohort, a large biracial, …

Currently available evidence strongly supports the position that the initiating event in
Alzheimer's disease (AD) is related to abnormal processing of β-amyloid (Aβ) peptide, ultimately …

In 2010, we put forward a hypothetical model of the major biomarkers of Alzheimer's disease
(AD). The model was received with interest because we described the temporal evolution of …

Based on the recent literature and collective experience, an international consortium developed
revised guidelines for the diagnosis of behavioural variant frontotemporal dementia. The …

To design clinical trials for the frontotemporal lobar degenerations (FTLD), knowledge about
measurement of disease progression is needed to estimate power and enable the choice of …